COMPARISON OF ANTI-FACTOR XA ACTIVITY VALUES ON EDOXABAN THERAPY IN RELATION TO BASELINE RENAL FUNCTION IN PATIENTS WITHATRIAL FIBRILLATION

被引：0
|
作者：
Ono, Ryohei
Fukushima, Kenichi
Takahashi, Hidehisa
Hori, Yasuhiko
Kobayashi, Yoshio
机构：
[1] Chiba Univ, Grad Sch Med, Chiba, Japan
[2] Matsudo City Gen Hosp, Matsudo, Chiba, Japan
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2021年 / 77卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1800 / 1800
页数：1
相关论文
共 50 条
  • [1] IMPACT OF RENAL FUNCTION ON ANTI-FACTOR XA ACTIVITY VALUES WITH EDOXABAN USE IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
    Ono, Ryohei
    Fukushima, Kenichi
    Takahashi, Hidehisa
    Hori, Yasuhiko
    Kobayashi, Yoshio
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 1788 - 1788
  • [2] Distribution of Anti-Factor Xa Activity in Patients on Edoxaban Therapy for Non-Valvular Atrial Fibrillation
    Osanai, Hiroyuki
    Ajioka, Masayoshi
    Masutomi, Tomohiro
    Kuwayama, Tasuku
    Ishihama, Sota
    Takahashi, Maki
    Kanbara, Takahiro
    Inoue, Yosuke
    Nakashima, Yoshihito
    Asano, Hiroshi
    Sakai, Kazuyoshi
    [J]. CIRCULATION JOURNAL, 2016, 80 (03) : 745 - 747
  • [3] Impact of Renal Function on Anti-factor Xa Activity Concentrations with Edoxaban Use in Patients with Non-valvular Atrial Fibrillation
    Ono, Ryohei
    Nishimura, Kazutaka
    Takahashi, Hidehisa
    Hori, Yasuhiko
    Fukushima, Kenichi
    Kobayashi, Yoshio
    [J]. DRUGS IN R&D, 2022, 22 (04) : 281 - 288
  • [4] Impact of Renal Function on Anti-factor Xa Activity Concentrations with Edoxaban Use in Patients with Non-valvular Atrial Fibrillation
    Ryohei Ono
    Kazutaka Nishimura
    Hidehisa Takahashi
    Yasuhiko Hori
    Kenichi Fukushima
    Yoshio Kobayashi
    [J]. Drugs in R&D, 2022, 22 : 281 - 288
  • [5] Distribution of anti-factor Xa activity in patients with nonvalvular atrial fibrillation receiving 15 mg dose of edoxaban
    Hiramatsu, Shotaro
    Osanai, Hiroyuki
    Sakai, Yuichiro
    Sogo, Yoshiki
    Tanaka, Yuki
    Matsumoto, Hikari
    Miyamoto, Shun
    Tagahara, Kensuke
    Arai, Kenji
    Watanabe, Takashi
    Sakamoto, Yusuke
    Sakaguchi, Teruhiro
    Oguchi, Shioh
    Kanbara, Takahiro
    Nakashima, Yoshihito
    Asano, Hiroshi
    Ajioka, Masayoshi
    [J]. JOURNAL OF ARRHYTHMIA, 2024,
  • [6] The Correlations Between Anti-Factor Xa Activity Values and Pt-inr/aptt at Peak and Trough Times in Patients on Edoxaban Therapy
    Ono, Ryohei
    Fukushima, Kenichi
    Hori, Yasuhiko
    Takahashi, Hidehisa
    Yamashita, Daichi
    Nishimura, Kaazutaka
    [J]. CIRCULATION, 2018, 138
  • [7] The Distribution of Anti-factor Xa Activity Values, Prothrombin Time and Activated Partial Thromboplastin Time Assessed at Multiple Points in Patients on Edoxaban Therapy
    Ono, Ryohei
    Fukushima, Kenichi
    Takahashi, Hidehisa R.
    Hori, Yasuhiko
    Kobayashi, Yoshio
    [J]. CIRCULATION, 2020, 142
  • [8] Comparison of Anti-factor Xa Activity Among Three Different Factor Xa Inhibitors in Non-valvular Atrial Fibrillation Patients with Renal Impairment
    Tobe, Akihiro
    Osanai, Hiroyuki
    Tanaka, Akihito
    Sakaguchi, Teruhiro
    Kambara, Takahiro
    Nakashima, Yoshihito
    Asano, Hiroshi
    Ishii, Hideki
    Ajioka, Masayoshi
    Murohara, Toyoaki
    [J]. CLINICAL DRUG INVESTIGATION, 2020, 40 (06) : 567 - 573
  • [9] Comparison of Anti-factor Xa Activity Among Three Different Factor Xa Inhibitors in Non-valvular Atrial Fibrillation Patients with Renal Impairment
    Akihiro Tobe
    Hiroyuki Osanai
    Akihito Tanaka
    Teruhiro Sakaguchi
    Takahiro Kambara
    Yoshihito Nakashima
    Hiroshi Asano
    Hideki Ishii
    Masayoshi Ajioka
    Toyoaki Murohara
    [J]. Clinical Drug Investigation, 2020, 40 : 567 - 573
  • [10] Comparison of Methods to Determine Rivaroxaban anti-factor Xa activity
    Rathbun, Suman
    Tafur, Alfonso
    Grant, Russell
    Esmon, Naomi
    Mauer, Karin
    Marlar, Richard A.
    [J]. THROMBOSIS RESEARCH, 2015, 135 (02) : 394 - 397
12345